Applying Microfluidics for the Production of the Cationic Liposome-Based Vaccine Adjuvant CAF09b
Subunit vaccines require particulate adjuvants to induce the desired immune responses. Pre-clinical manufacturing methods of adjuvants are often batch dependent, which complicates scale-up for large-scale good manufacturing practice (GMP) production. The cationic liposomal adjuvant CAF09b, composed...
Saved in:
Main Authors: | Signe Tandrup Schmidt (Author), Dennis Christensen (Author), Yvonne Perrie (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators
by: Signe Tandrup Schmidt, et al.
Published: (2016) -
Application of Pharmacokinetics Modelling to Predict Human Exposure of a Cationic Liposomal Subunit Antigen Vaccine System
by: Raj K. S. Badhan, et al.
Published: (2017) -
Adjuvant Effect of Cationic Liposomes for Subunit Influenza Vaccine: Influence of Antigen Loading Method, Cholesterol and Immune Modulators
by: Alexander Kros, et al.
Published: (2013) -
Development of novel cationic microemulsion as parenteral adjuvant for influenza vaccine
by: Sakalanunt Lamaisakul, et al.
Published: (2020) -
The cationic liposome CCS/C adjuvant induces immunity to influenza independently of the adaptor protein MyD88
by: Orli Even-Or, et al.
Published: (2020)